Log in

LON:VLGVenture Life Group Share Price, Forecast & News

GBX 70
+3.75 (+5.66 %)
(As of 05/27/2020 02:32 AM ET)
Add
Compare
Today's Range
66.60
Now: GBX 70
70
50-Day Range
41.50
MA: GBX 56.80
68
52-Week Range
20
Now: GBX 70
72
Volume644,223 shs
Average Volume8,687 shs
Market Capitalization£58.60 million
P/E Ratio70.00
Dividend Yield0.09%
BetaN/A
Venture Life Group Plc develops and commercializes oral care products, food supplements, medical devices, and dermo-cosmetics for the ageing population in the United Kingdom, Europe, and internationally. It operates through Brands, and Development and Manufacturing segments. The company offers cardiovascular product for lowering cholesterol in food supplement; and neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain. It also provides Original Bioscalin to treat and prevent hair loss and scalp problems, as well as hair thinning and baldness; Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX Original and UltraDEX Sensitive for bad breath; Procto-eze for anal irritation, including haemorrhoids conditions; and Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and mouth. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei vaginal atrophy, a topical cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name. Venture Life Group plc sells its products through a network of partners selling into the pharmacy channel. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Read More
Venture Life Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.91 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1344-742870

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£20.21 million
Cash FlowGBX 13.18 per share
Book ValueGBX 39.20 per share

Profitability

Miscellaneous

Employees106
Market Cap£58.60 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VLG News and Ratings via Email

Sign-up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter.

Venture Life Group (LON:VLG) Frequently Asked Questions

How has Venture Life Group's stock been impacted by COVID-19 (Coronavirus)?

Venture Life Group's stock was trading at GBX 32.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, VLG shares have increased by 115.4% and is now trading at GBX 70. View which stocks have been most impacted by Coronavirus.

Has Venture Life Group been receiving favorable news coverage?

Media headlines about VLG stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Venture Life Group earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutVenture Life Group.

Who are some of Venture Life Group's key competitors?

What other stocks do shareholders of Venture Life Group own?

Who are Venture Life Group's key executives?

Venture Life Group's management team includes the following people:
  • Mr. Jeremy Anthony Philip Randall, CEO & Exec. Director (Age 54)
  • Ms. Sharon Mary Daly, Co-Founder, Chief Commercial Officer & Exec. Director (Age 44)
  • Mr. Lodovico Gianluca Braguti, Chief Manufacturing Officer & Exec. Director
  • Mr. Mark Andrew Waters, Chief Financial Officer (Age 52)
  • Mr. Domenico Barbaro, Head of Procurement

What is Venture Life Group's stock symbol?

Venture Life Group trades on the London Stock Exchange (LON) under the ticker symbol "VLG."

How do I buy shares of Venture Life Group?

Shares of VLG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Venture Life Group's stock price today?

One share of VLG stock can currently be purchased for approximately GBX 70.

How big of a company is Venture Life Group?

Venture Life Group has a market capitalization of £58.60 million and generates £20.21 million in revenue each year. Venture Life Group employs 106 workers across the globe.

What is Venture Life Group's official website?

The official website for Venture Life Group is www.venture-life.com.

How can I contact Venture Life Group?

Venture Life Group's mailing address is Venture House 2 Arlington Square, Downshire Way, BRACKNELL, RG12 1WA, United Kingdom. The company can be reached via phone at +44-1344-742870.

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.